Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
February 2, 2024
When building a disease model or an economic model, the assumption has been that updates to such models should only...
Read article
May 27, 2022
How to Use a Living HTA Approach to Demonstrate Value in Real-Time
When submitting systematic literature reviews to a Health Technology Assessment authority, high volumes of research...
Read article
May 4, 2022
Optimizing Human-Machine Partnership for Up-To-Date Evidence
If you are a pharmaceutical or biotech company seeking to enter the market with a new drug, you need to submit a...
Read article
April 1, 2022
A Spotlight on Our Scientific Community
At the end of every year, scientists from across Cytel’s business units are nominated for Cytel’s Spotlight Awards,...
Read article
May 13, 2021
An Interview with Radek Wasiak, Head of Real World and Advanced Analytics at Cytel
Cytel’s HEOR and RWE Expertise has grown quite significantly in the past year. Could you speak a little bit about the...
Read article